ResearcherTohoku UniversityActive in the last 2 years
Kazuhiko Igarashi
Matched on ORCID iD 0000-0002-2470-2475; OpenAlex author ID A5114376003. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 25
2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 5
- Polyunsaturated fatty acids-induced ferroptosis suppresses pancreatic cancer growth. Co-author DOI 10.1038/s41598-024-55050-4↗
- BACH1 Expression Is Promoted by Tank Binding Kinase 1 (TBK1) in Pancreatic Cancer Cells to Increase Iron and Reduce the Expression of E-Cadherin. Last author DOI 10.3390/antiox11081460↗
- Novel candidate factors predicting the effect of S-1 adjuvant chemotherapy of pancreatic cancer. Co-author DOI 10.1038/s41598-021-86099-0↗
- BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition. Last author DOI 10.1158/0008-5472.can-18-4099↗
- Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0235904↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michiaki Unno · 3 shared papers, 2020–2021 · strength 0.30
- Paper Novel candidate factors predicting the effect of S-1 adjuvant chemotherapy of pancreatic cancer. DOI 10.1038/s41598-021-86099-0↗
- Paper BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transit… DOI 10.1158/0008-5472.can-18-4099↗
- Paper Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma. DOI 10.1371/journal.pone.0235904↗
- Yuriko Saiki · 2 shared papers, 2020–2024 · strength 0.27
- Masamichi Mizuma · 2 shared papers, 2020–2021 · strength 0.21
- Yoshiteru Kagawa · 1 shared paper, 2024 · strength 0.18
- Akane Suda · 1 shared paper, 2024 · strength 0.18
- Toru Furukawa · 1 shared paper, 2024 · strength 0.18
- Liang Liu · 1 shared paper, 2022 · strength 0.15
- Katsutaka Mitachi · 1 shared paper, 2021 · strength 0.12
- Shimpei Maeda · 1 shared paper, 2021 · strength 0.12
- Kyohei Ariake · 1 shared paper, 2021 · strength 0.12
- Yukinari Kato · 1 shared paper, 2020 · strength 0.09
- Mika Kato Kaneko · 1 shared paper, 2020 · strength 0.09
- Keiko Nakayama · 1 shared paper, 2020 · strength 0.09
- Shinji Yamada · 1 shared paper, 2020 · strength 0.09
- Masaki Sato · 1 shared paper, 2020 · strength 0.09
- Kei Kawaguchi · 1 shared paper, 2020 · strength 0.09
- Tatsuo Hata · 1 shared paper, 2020 · strength 0.09
- Tatsuyuki Takadate · 1 shared paper, 2020 · strength 0.09
- Kei Nakagawa · 1 shared paper, 2020 · strength 0.09
- Mitsuhiro Shimura · 1 shared paper, 2020 · strength 0.09
- Masahiro Iseki · 1 shared paper, 2020 · strength 0.09
- Yukie Suzuki · 1 shared paper, 2020 · strength 0.09
- Takashi Suzuki · 1 shared paper, 2020 · strength 0.09
- Takanori Morikawa · 1 shared paper, 2020 · strength 0.09
- Fuyuhiko Motoi · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.